2004N-0133 - Part 11 Public Meeting; June 11, 2004
FDA Comment Number : EC19
Submitter : Mr. Peter Robertson Date & Time: 09/07/2004 07:09:04
Organization : AstraZeneca
International Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
Please see attached comments in response to the specific questions raised in the request for comments on Part 11 review.

AstraZeneca appreciates this opportunity to contribute to the discussion.